UMIN ID: UMIN000044940
Registered date:22/07/2021
Efficacy and Safety of Nepcell STM to Achieve Hemostasis after Removal of a 15-French Caliber Femoral Venous Sheath in Patients Undergoing Cryoballoon Ablation of Atrial Fibrillation.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | atrial fibrillation |
Date of first enrollment | 2021/07/22 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Nepcell group conterol |
Outcome(s)
Primary Outcome | time to hemostasis |
---|---|
Secondary Outcome | internal hemorrhage, re-bleeding, duration of hospital stay, and 1-month vascular complications |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 90years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | HD |
Related Information
Primary Sponsor | Steel Memorial Yawata Hospital Cardiovascular Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | none |
Secondary ID(s) |
Contact
public contact | |
Name | Masao Takemoto |
Address | 1-1-1 Harunomachi, Yahatahigashi-ku Japan 805-8508 |
Telephone | 093-672-3176 |
matakemo@kc4.so-net.ne.jp | |
Affiliation | Steel Memorial Yawata Hospital Cardiovascular Center |
scientific contact | |
Name | Masao Takemoto |
Address | 1-1-1 Harunomachi, Yahatahigashi-ku Japan |
Telephone | 093-672-3176 |
matakemo@kc4.so-net.ne.jp | |
Affiliation | Steel Memorial Yawata Hospital Cardiovascular Center |